Making the Most of Vaccine Tech

Scientists are riding the wave of innovations driving COVID-19 vaccine technology and applying them to less headline-grabbing neglected diseases.
One of them is Arturo Reyes-Sandoval, of the National Vaccine Development Centre at Mexico City’s Instituto Politécnico Nacional. He helped develop the “ChAdOx” technology used in the AstraZeneca COVID-19 vaccine, which uses a chimpanzee adenovirus as a vector.
The platform can accept a “genetic cassette, which you can plug-and-play for many diseases.”
Now, he is deploying that technology to develop vaccines for neglected diseases from Chagas to dengue, yellow fever, and chikungunya—for which the team has already seen promising results.  
A major bonus: The platform does spread throughout the body, meaning it could be ideal for the immunocompromised.
The Telegraph

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top